Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

New methods for automated phenotyping of complex cellular behaviors.

Hack AA, Ahouse J, Roberts PG, Garakani AM.

Conf Proc IEEE Eng Med Biol Soc. 2004;7:5124-6.

PMID:
17271475
2.

Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle.

Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM.

J Cell Sci. 2004 Aug 1;117(Pt 17):3821-30. Epub 2004 Jul 13.

3.

Secondary coronary artery vasospasm promotes cardiomyopathy progression.

Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, Zarnegar S, Earley JU, Lang RM, McNally EM.

Am J Pathol. 2004 Mar;164(3):1063-71.

4.

Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.

Porter JD, Merriam AP, Hack AA, Andrade FH, McNally EM.

Neuromuscul Disord. 2001 Mar;11(2):197-207.

PMID:
11257478
5.

Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.

Cordier L, Gao GP, Hack AA, McNally EM, Wilson JM, Chirmule N, Sweeney HL.

Hum Gene Ther. 2001 Jan 20;12(2):205-15.

PMID:
11177557
6.

Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.

Cordier L, Hack AA, Scott MO, Barton-Davis ER, Gao G, Wilson JM, McNally EM, Sweeney HL.

Mol Ther. 2000 Feb;1(2):119-29.

7.

Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM.

J Cell Sci. 2000 Jul;113 ( Pt 14):2535-44.

8.

Sarcoglycans in muscular dystrophy.

Hack AA, Groh ME, McNally EM.

Microsc Res Tech. 2000 Feb 1-15;48(3-4):167-80. Review.

PMID:
10679964
9.

Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein.

Thompson TG, Chan YM, Hack AA, Brosius M, Rajala M, Lidov HG, McNally EM, Watkins S, Kunkel LM.

J Cell Biol. 2000 Jan 10;148(1):115-26.

10.

Muscle degeneration without mechanical injury in sarcoglycan deficiency.

Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10723-8.

11.

Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting.

Sterpetti P, Hack AA, Bashar MP, Park B, Cheng SD, Knoll JH, Urano T, Feig LA, Toksoz D.

Mol Cell Biol. 1999 Feb;19(2):1334-45. Erratum in: Mol Cell Biol 1999 May;19(5):3930.

12.

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM.

J Cell Biol. 1998 Sep 7;142(5):1279-87.

13.

PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation.

Olson MC, Scott EW, Hack AA, Su GH, Tenen DG, Singh H, Simon MC.

Immunity. 1995 Dec;3(6):703-14.

Supplemental Content

Support Center